Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.017 | 0.7 |